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Troponin C (TnC), a calcium-binding protein of the thin filament of muscle, plays a regulatory
role in skeletal and cardiac muscle contraction. NMR reveals a small conformational change in
the cardiac regulatory N-terminal domain of TnC (cNTnC) on binding of Ca21 such that the
total exposed hydrophobic surface area increases very slightly from 3090 6 86 Å2 for
apo-cNTnC to 3108 6 71 Å2 for Ca21-cNTnC. Here, we show that measurement of solvent
accessibility for backbone amide protons by means of solution-phase hydrogen/deuterium
(H/D) exchange followed by pepsin digestion, high-performance liquid chromatography, and
electrospray ionization high-field (9.4 T) Fourier transform Ion cyclotron resonance mass
spectrometry is sufficiently sensitive to detect such small ligand binding-induced conforma-
tional changes of that protein. The extent of deuterium incorporation increases significantly on
binding of Ca21 for each of four proteolytic segments derived from pepsin digestion of the
apo- and Ca21-saturated forms of cNTnC. The present results demonstrate that H/D exchange
monitored by mass spectrometry can be sufficiently sensitive to detect and identify even very
small conformational changes in proteins, and should therefore be especially informative for
proteins too large (or too insoluble or otherwise intractable) for NMR analysis. (J Am Soc
Mass Spectrom 1999, 10, 703–710) © 1999 American Society for Mass Spectrometry
For about three decades, protein amide hydrogenisotopic exchange rates have provided informa-tion about the higher-order structure, structural
changes, and structural dynamics of proteins [1–5].
With the advent of electrospray ionization mass spec-
trometry (ESI-MS), hydrogen/deuterium exchange for
a protein as a whole could be monitored quickly and
easily by mass spectrometry (MS), to characterize pro-
tein denaturation [6], folding intermediates [7], confor-
mational states [8–10], and structural perturbations
induced by binding of ligands or other proteins [11].
H/D exchange followed by proteolytic digestion and
on-line liquid chromatography/mass spectrometry
(LC/MS) serves to localize the solvent accessibility
within individual peptide segments of a protein [12–14].
That approach makes it possible to define the effect of
mutations on protein stability [15–18], and to character-
ize higher-order structure and dynamics of proteins
[19–21] as well as protein conformational changes in-
duced by ligand binding [9, 18, 22]. In particular,
Fourier transform ion cyclotron resonance mass spec-
trometry (FT-ICR MS) offers several advantages for
H/D exchange analysis because of its ultrahigh mass
resolving power [23–32]. Finally, the upper mass limit
for FT-ICR MS (and the precision with which the
number of incorporated deuteriums may be measured)
may be extended by almost an order of magnitude by
expression of the protein from media doubly depleted
in 13C and 15N [33].
Troponin C (TnC) is a calcium-binding protein of the
thin filament of muscle and plays a regulatory role in
skeletal and cardiac muscle contraction. The conforma-
tional changes of TnC induced by Ca21 binding are
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believed to be transmitted via the linkage between TnC
and TnI (troponin I) within the three-subunit troponin
complex, so as to initiate a cascade of structural changes
in the thin filament complex leading to muscle contrac-
tion [34]. The two isoforms of the TnC are found in fast
skeletal muscle TnC (sTnC) and slow skeletal and
cardiac muscle TnC (cTnC). The X-ray structure of
avian sTnC shows a highly a-helical protein with two
domains: C-terminal and N-terminal [35]. Each domain
contains two Ca21-coordinating E-F hands: i.e., two
perpendicular a-helices and a 12 amino residue loop
between them. The two Ca21 binding sites (I and II) in
the N terminus of TnC are regulatory sites [36–39] and
have a lower affinity for Ca21 relative to the structural
binding sites (III and IV) [40] in the C terminus of TnC.
The measured Ca21 binding constant for (regulatory)
site II in the N domain is the same as that measured for
intact cardiac TnC [41]; similarly, Ca21 binding to the N
domain of skeletal TnC remains unchanged when it is
separated from intact skeletal TnC [42, 43]. Thus, NMR
analysis has concentrated on the smaller N domain
rather than on the full troponin C protein.
The solution NMR structure of the N-terminal do-
main of skeletal TnC (sNTnC) reveals an “opening” of
the structure and the concomitant exposure of a sub-
stantial hydrophobic surface area upon Ca21 binding to
sNTnC [44]. The primary structure of cNTnC is highly
similar to that of sNTnC. However, site-specific muta-
tion of critical side chains (D29L and D31A) and an
insertion (Val-28) in cNTnC abolish the ability of one of
the regulatory Ca21-binding sites to coordinate Ca21. In
contrast, NMR fails to show any opening of the domain
and the concomitant exposure of a substantial hydro-
phobic surface area for cardiac N-domain TnC (cNTnC)
upon binding of Ca21 [41, 45, 46]. cNTnC remains
essentially in the “closed” conformation in its Ca21-
saturated state, with only a minor conformational
change compared to apo-cNTnC.
Therefore, in this paper, we undertake to measure
backbone amide hydrogen/deuterium exchange for hu-
man apo- and Ca21-saturated forms of the N domain
isolated from human cardiac TnC by use of LC-ESI
FT-ICR MS, to see if mass spectrometry can detect small
Ca21-induced conformational changes barely detectable
by NMR.
Experimental
Protein Preparation
Plasmid for the expression of the N domain of cardiac
troponin C was provided by Dr. Murali Chandra in the
laboratory of Professor R. John Solaro in the Depart-
ment of Physiology and Biophysics, College of Medi-
cine, University of Illinois, Chicago. E. coli cells, strain
BL21(DE3)pLysS, were transformed according to stan-
dard methodologies [45]. Several colonies from the
plates of the transformed cells were used to inoculate
TY media (NaCl 2.5 gm/L Bacto-trytone 8.0 gm/L;
yeast extract 5.0 gm/L) which were grown to O.D. 1.0.
5 mL of these cells were used to inoculate 500 mL of
limited media (NaH2PO4—12 gm/L; K2HPO4—6
gm/L; NH4SO4—1.1 gm/L; glucose—3 gm/L). All cul-
tures were grown with the addition of 1 mL/L of 5%
ampicillin solution and 1 mL/L of 2.5% chloramphen-
icol solution. 99.9% 15N depleted ammonium sulfate
and 99.9% 13C depleted glucose, both obtained from
Isotech (Miamisberg, OH), constituted the sole nitrogen
and carbon sources, respectively. Cells were grown
under these conditions to O.D. 0.71, induced with IPTG,
and allowed to incubate for 3 h. The cells were then
centrifuged and resuspended in 50 mM tris HCl buffer
at pH 8.0, French-pressed, and the lysate applied to a
100 ml DEAE A-25 Sepharoset column. The purified
protein was eluted with 1 L of a 0.10 3 0.55 M NaCl
gradient in 50 mM Tris HCl, 2 mM MgCl2 buffer, and
then dialyzed for 3 days versus deionized H2O with
mercaptoethanol present, and lyophilized [41].
Materials
Pepsin was obtained from Worthington, Co. (Lake-
wood, NJ), and D2O (99.9 atom % D) from Aldrich
Chemical Co. (Milwaukee, WI). All other chemicals and
reagents were of the highest grade commercially avail-
able.
Hydrogen Exchange
H/D exchange was initiated by 20-fold dilution,
namely, by adding 20 mL of a 1 mM 13C, 15N-depleted
cNTnC solution in 10 mM imidazole buffer, pH 6.7, 100
mM KCl, 15 mM DTT, and 10 mM EDTA (for Ca21-free
TnC) or 10 mM CaCl2 (for Ca
21-saturated cNTnC), to
380 mL of 99.9 atom% D2O buffer containing 10 mM
imidazole and 100 mM KCl, pHreading 6.3. Solutions
were maintained at 25 °C in a water bath, and incubated
for each of several H/D exchange periods. At appropri-
ate intervals, aliquots of the cNTnC solution were
quenched by the addition of an equal volume of 0.5 M
phosphate buffer, pH 2.2 in H2O, and immediately
frozen in liquid N2. The samples were stored at 270 °C
until analysis.
Pepsin Digestion
The deuterated protein was thawed on ice. A 90-mL
aliquot of deuterated protein solution was added to 14
mL of 80 mM pepsin in 0.5 M phosphate buffer, pH 2.2,
injected onto a 10-mL injection loop, and allowed to
digest for 3 min at 0 °C in the loop prior to HPLC
analysis.
LC-ESI FT-ICR MS Analysis of the Digested
Peptides of Deuterated cNTnC
Extent of deuterium incorporation into cNTnC and
localization was determined by LC-ESI FT-ICR MS
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analysis. Acetonitrile gradients at 30 mL/min were
generated with a Shimadzu HPLC equipped with two
LC-10AD pumps. Solvent A was 94.5% H2O containing
5% acetonitrile and 0.5% formic acid (pH 2.3), and
solvent B was 80% acetonitrile containing 19.5% H2O
and 0.5% formic acid. A low volume static mixing tee
was used to minimize the delay period for HPLC. The
solvent precooling coil, static mixing tee, Rheodyne
injector, and column were immersed in an ice bath
(0 °C) to minimize back exchange with HPLC solvents.
Aliquots (10 mL) of the exchanged and quenched pepsin
digests were loaded onto a Vydac 1.0 3 50 mm C4 or C8
column, respectively. After desalting at 5% B for 2 min,
the peptic peptides eluted between 4.2 and 6.5 min with
a 7-min 5%–50% B gradient. The column effluent (30
mL/min) was delivered directly to the mass spectrom-
eter without flow split.
To account for deuterium gain or loss under
quenched conditions, we prepared two control samples
[12]. A “zero-deuteration” control was prepared by
diluting the protein solution directly into a 1:1 (v/v)
mixture of deuterated buffer and quench buffer. A
“full-deuteration” control was prepared by 1:20 (v/v)
dilution of cNTnC into 2 M urea-d4 in D2O solution and
incubation for 1.0 h at 55 °C. The deuterium content, D,
for each partially deuterated protein (or segment) may
be calculated from [13]:
D 5
m 2 m0%
m100%2m0%
3H (1)
in which H is the total number of backbone amide
hydrogens in the protein (or its segment), e.g., H 5 86
for cNTnC after taking into account that the N-terminal
residue and proline linkages have no exchangeable
amide hydrogens. In eq 1, m0%, m, and m100% are the
average (i.e., the centroid of the isotope envelope)
molecular weights for the 0% control, partially deuter-
ated, and 100% control protein. All deuterium contents
reported in this paper were calculated from eq 1, in
which H is the total number of backbone amide hydro-
gens for the segment in question. Back exchange for
each proteolytic peptide was determined from the dif-
ference between the theoretical mass for maximally
(95% D2O) amide-deuterated species and the experi-
mental mass determined after LC/MS analysis. For the
intact protein, the extent of back exchange was ;19%
(versus 38%–62% for various proteolytic peptides) dur-
ing quench and LC/MS analysis. Those values are
consistent with the 40%–50% of overall back exchange
reported by other authors [16, 20] and more recent
18%–55% values [18, 22].
Identification of Proteolytic Segments
cNTnC was digested with pepsin (;2:1 substrate:en-
zyme mole ratio) at pH meter reading 2.2 and 0 °C for
3 min, then subjected to HPLC/MS analysis. Mass
resolving power, m/Dm50%, (in which Dm50% is the
mass-domain peak full width at half-maximum peak
height) ranged between 50,000 and 120,000, depending
on the peptide mass-to-charge ratio (m/z).
Mass Spectrometry
Mass analyses were performed with a homebuilt FT-
ICR mass spectrometer, based on a passively shielded
9.4 tesla 200-mm diameter horizontal-bore supercon-
ductive magnet, and equipped with a homebuilt exter-
nal electrospray interface described elsewhere [25, 47].
An Odyssey™ data system (Finnigan FTMS, Madison,
Wisconsin) acquired time-domain ICR data, Fourier
transformed it, applied Hanning apodization, and pro-
cessed the discrete mass spectrum into a peak list.
Direct-mode excitation was by frequency sweep from
480,988 Hz (m/z 300 for peptides) at a sweep rate of 130
Hz ms21. Time-domain data size was 128 kword. The
Figure 1. Amino acid sequence of cNTnC, showing the pepsin-
cleaved mass-identified fragments (double-ended arrows) for
which deuterium incorporation was measured.
Table 1. Illustration of peptic peptide identification based on
FT-ICR accurate mass measurement. The experimental peptide
monoisotopic mass (i.e., all carbons are 12C, all nitrogens are
14N, all oxygens are 18O, all hydrogens are 1H, and all sulfurs
are 32S) is 829.65 6 0.09 for (M 1 4H)41, or M 5 (829.65 * 4) 2
(4 * 1.0073) 5 3314.6 6 0.4 Da. [The mass of a proton is
1.0078 (1H atom) 2 0.0005 (electron) 5 1.0073.] The table lists all
of the possible cNTnC fragment monoisotopic masses within 1.5
Da of the experimental value. Only one, [C] I36-V64 [D], falls
within 100 ppm, and identifies the correct fragment. The
brackets denote the amino acid preceding the amino-terminus
(or following the carboxy-terminus) of the segment before
proteolysis.
Peptide
segment
Monoisotopic
mass
Deviation from
experimental
value (ppm)
[E] E14-G43 [K] 3315.63 313
[Q] K17-R46 [M] 3315.70 333
[C] I36-V64 [D] 3314.65 18
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peak list was further analyzed with homewritten soft-
ware to display the extent of deuterium uptake by
pepsin-digest peptides [21].
Results and Discussion
Deuterium Incorporation for Intact cNTnC
TnC is an EF-hand calcium-binding protein of thin
filaments, with a single polypeptide chain molecular
weight of 18 kDa. It consists of similar N- and C-
terminal globular domains (NTnC and CTnC). The
cardiac N-terminal domain of troponin C (cNTnC)
contains one Ca21-binding regulatory site (2.6-mM dis-
sociation constant). The NMR structure of cNTnC con-
tains five a-helices (N, A, B, C, D) and two short
b-sheets [45]. The B and C helices reorient slightly
relative to the NAD unit upon Ca21 binding. For H/D
exchange of Ca21-saturated cNTnC, we used 500 mM of
Ca21 and 50 mM cNTnC, so that ;96% of the cNTnC
should be in the Ca21-bound form. Although Ca21 is
present at 10-fold excess over protein (to ensure high
saturation of strong-site Ca21 binding), prior NMR
shows that the resulting nonspecific Ca21 binding does
not affect the protein conformation [41].
Mass Spectrometric Identification of Pepsin-
Cleavaged Segments of cNTnC
We performed H/D exchange followed by pepsin di-
gestion to cleave the protein somewhat nonspecifically
to yield many peptide fragments, each of which could
then be identified (and its deuterium uptake deter-
mined) by ESI FT-ICR MS. The peptic peptides derived
from cNTnC could be assigned from data from a single
LC run by ESI FT-ICR MS with external calibration (,30
ppm mass accuracy). Use of 13C, 15N isotopically doubly
depleted protein made it possible to assign each of the
various peptic peptides solely from its accurate mo-
noisotopic mass (i.e., no need for tandem mass spec-
trometry). For example (see Table 1), search of the
cNTnC amino acid sequence yields three peptides (res-
idues 14–43, 17–46, and 36–64), each of whose mo-
noisotopic molecular mass agrees to within ;1.5 Da
with a particular experimental peptide mass of
3314.6 6 0.4 Da. However, the monoisotopic mass of
only one of those peptides (residues 36–64) falls within
100 ppm of the experimental value. Remarkably, 10 of
the 12 peptic peptides generated from cNTnC could be
Figure 2. Time course for deuterium uptake for each of three
different segments from cNTnC in the presence (open circle) or
absence (open square) of Ca21, each showing no difference in rate
of deuterium uptake upon Ca21 binding. The number of poten-
tially exchangeable backbone amide hydrogens in each segment is
shown in each panel.
Figure 3. Time course for deuterium uptake for each of four
other segments from cNTnC in the presence (open circle) or
absence (open square) of Ca21, each showing significant increase
in rate of deuterium uptake upon Ca21 binding. The number of
potentially exchangeable backbone amide hydrogens in each
segment is shown in each panel.
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identified in this way! For the remaining 2, more than one
peptide sequence matched the experimental mass to
within 100 ppm, but the correct peptide could be
assigned, based on the previously identified cleavage
sites. In all, we identified 12 segments, spanning 100%
of the cNTnC primary amino acid sequence (see
Figure 1).
Deuterium Incorporation for Various Proteolytic
Segments
We measured the time course for deuterium incorpora-
tion for each of the 12 available proteolytic peptide
segments derived from cNTnC. Figure 2 shows that the
proteolytic segments spanning residues 1–11, 8–24, and
25–29 show no significant difference in extent of deute-
rium incorporation between apo- and Ca21-saturated
forms of cNTnC. However, nine other segments (four of
which, spanning residues 28–56, 36–56, 36–64, and
60–89, are shown in Figure 3) exhibited a pronounced
increase in extent of deuterium incorporation for Ca21-
complexed cNTnC relative to cNTnC. For example, the
number of deuteriums incorporated into segment V28-
E56 increases by 3 (i.e., ;10% of a segment consisting of
27 amino acids) on Ca21 binding, after correction for
back exchange during the quenching, pepsin digestion,
and LC-MS analysis steps. Although small, the differ-
ence of 3 Da is much larger than experimental error (see
Figure 4), because our LC-ESI FT-ICR MS measure-
ments from three independent runs (including errors
introduced from H/D exchange, quenching, pepsin
digestion, HPLC, and FT-ICR MS), are reproducible to
within 0.5 Da [18]. As a further test, we repeated the
H/D exchange of cNTnC for 2 h, both in the apo- and
Ca21-saturated forms of cNTnC, and again observed a
statistically significant increase in deuterium incorpora-
tion into the same four segments for Ca21-complexed
cNTnC relative to cNTnC.
We have previously pointed out that H/D exchange
is best quantitated by its rate, rather than by the extent of
exchange after a particular H/D exchange period [21].
We therefore subjected each deuterium uptake versus
Figure 4. ESI FT-ICR mass spectra of the V28-E56 [M 1 3H]31 ion pepsin-cleaved segment from 13C,
15N-depleted cNTnC, following each of various periods of solution-phase H/D exchange. Lower:
apo-cNTnC. Upper: Ca21-saturated cNTnC. Note the small (but detectable) increase in deuterium
uptake on binding of Ca21.
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time profile to maximum entropy method (MEM) anal-
ysis to determine the most probable rate constant dis-
tribution for the (known) number of exchangeable pro-
tons in each segment [18, 21]. MEM H/D exchange rate
constant distributions corresponding to the deuterium
uptake curves in Figure 4 are shown in Figure 5. For
well-resolved peaks, the (linear) ordinate in Figure 5 is
scaled so that the total area under each peak corre-
sponds to the total number of amide hydrogens (listed
above each peak) over the range of exchange rate
constants spanning that peak [21]. However, for rate
constants too slow (or too fast) to be determined from
the experimental data, the MEM rate constant distribu-
tion levels off to a horizontal line extending infinitely to
the left (or right) in Figure 5.
Interpretation of MEM rate constant distributions is
simple. For example, for segment V28-E56 (Figure 5,
upper left), two slowly exchanging amide hydrogens (k
#1022 h21) for apo-cNTnC speed up to an intermediate
exchange rate (1021 h21 # k # 102 h21) on binding of
Ca21. Finally, for reference, each panel in Figure 5 also
lists the total number of potentially exchangeable amide
hydrogens for a given segment.
Visualization of Effects of Calcium Binding on
cNTnC Solvent Accessibility
Although it is possible to infer conformational changes
on binding of Ca21 within individual segments of
cNTnC from the observed differences in exchange rate
constant distributions (Figure 5), we find it easier to
consider the results graphically by shading the seg-
ments of a three-dimensional NMR ribbon structure of
cNTnC (Figure 6). In this case, segments exhibiting
increased H/D exchange on Ca21 binding are shaded
darker. In Figure 6, residues 1–11 include helix N (5–11);
residues 8–24 include most of helix A (14–26); residues
36–56 include helix B (38–48) and the turn between the
B and C helices; residues 28–56 include the turn be-
tween the A and B helices comprising calcium binding
site I (28–40), helix B (38–48) and the turn between the
B and C helices; residues 36–64 include helix B (38–48),
the turn between the B and C helices, and helix C
(54–64); and residues 60–89 include helix C (54–64),
the turn between the C and D helices comprising
calcium binding site II (65–76), and helix D (74–84).
Small Conformational Changes Measured by H/D
Exchange and LC-ESI FT-ICR MS
Small conformational changes previously detected by
H/D exchange and LC-ESI-MS include a minor confor-
mational difference between oxidized and reduced cy-
tochrome c [48] and a small change resulting from point
mutations of a bacterial phosphocarrier protein [16]; the
Gibbs free energy (DG) of folding for two mutants is
greater than that for the wild type by 1.5 and 0.5
kcal/mol, based on urea denaturation. DG of folding for
cardiac TnC is not known. However, DG of unfolding
for Ca21-saturated skeletal NTnC is greater than that
for apo-NTnC by 1.3 kcal/mol [49] based on thermal
denaturation. NMR reveals a large-scale movement of
helices B and C of sNTnC away from helices N, A, and
D after Ca21 binding [50], whereas cNTnC exhibits only
minor reorientation of the B and C helices relative to the
N/A/D unit on Ca21 binding [45].
The opening of the structure and the exposure of
hydrophobic patch are evidently energetically unfavor-
able for cNTnC [51]. Specifically, the total exposed
hydrophobic surface area increases dramatically (by 520
Å2) from 2866 Å2 for apo-sNTnC to 3386 Å2 for Ca21-
sNTnC, but increases almost undetectably (by 18 Å2, from
3090 6 86 to 3108 6 71 Å2) for the corresponding cardiac
isoform [45]. Remarkably, we are easily able to detect this
small conformational change of cNTnC upon calcium
binding by H/D exchange coupled with pepsin digestion
and LC-ESI FT-ICR MS, because we can determine the
number of incorporated deuteriums to within 0.5 Da, or to
within at most ;3% in that segment by FT-ICR MS [18],
compared to within ;5% in prior reports [12, 15].
In summary, solution-phase H/D exchange coupled
with proteolytic digestion, high-performance liquid
chromatography and ESI FT-ICR MS provides a sensi-
Figure 5. H/D exchange rate constant distributions derived
from the H/D exchange time course for each of the four different
segments shown in Figure 4: apo-cNTnC (———) and Ca21-
saturated cNTnC (– – – –). The total number of backbone amide
hydrogens for each segment is indicated in each panel. The number
of backbone amide hydrogens for each resolved peak in the MEM-
derived rate constant distribution is shown above that peak.
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tive method for the measurement of small ligand-
induced conformational or dynamic changes in a pro-
tein. Here, we have detected the small reorientation of
the B and C helices relative to the N, A, and D helices of
the N-terminal domain of human cardiac troponin C
upon Ca21 binding. Although more detailed structural
details can in principle be obtained by NMR or X-ray
crystallography, the mass spectrometry-based approach
consumes vastly less sample and requires much less
time for analysis. For example, NMR requires ;3
mM 3 0.5 ml 5 1.5 mmol, or ;15 mg for a 10K protein;
where as mass spectrometry requires 10 kinetic runs,
each ;25 mM 3 15 mL 5 10 3 375 pmol, or ;40 mg for
a 10K protein. Moreover, mass spectrometry is available
for proteins too large (or aggregated or insoluble) for
NMR analysis.
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